Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives
Microorganisms · 20.02.2024 · 12 (3) · 430
DOI: 10.3390/microorganisms12030430 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 20.02.2024. Verfasst von Mohamed E Abouelela und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA. Die Arbeit wurde bisher 252-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIGMS NIH HHS, U.S. Department of Agriculture (USDA) National Institute for Food and Agriculture (NIFA).
Abstract (Originalsprache)
Next-generation probiotics (NGPs) represent an innovative group of beneficial bacteria that are currently undergoing research and development. NGPs are designed not only for conventional use as foods or dietary supplements but are also tailored for pharmaceutical applications. Research indicates that NGPs show therapeutic promise in addressing various chronic ailments. Offering multiple advantages over conventional probiotics, NGPs present opportunities for personalized probiotic therapies, involvement in synthetic biology and gene editing, participation in combination therapies, targeted delivery methods, and application in therapeutic settings. Our review discusses the potential therapeutic effect of the NGPs, covering diverse research trajectories for NGPs, including their identification, characterization, and targeted delivery. Furthermore, this review elucidates the influence of NGPs on critical aspects of human health, specifically, gut health, immune function, and broader health outcomes. Mechanistic insights encompass the production of bioactive compounds, competitive interactions with pathogenic bacteria, the modulation of immune cell activity, and the reinforcement of the gut barrier. What is noteworthy is that the current review points out the prevalent NGP strains and their diverse sources, providing a highlight for the comprehensive framework for understanding their potential applications and their future benefits in the domain of advanced therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
- Department of Veterinary Science, Martin-Gatton College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY 40546, USA.
ORCID-Profile: Mohamed E Abouelela, Yosra A Helmy
Förderung
- NCATS NIH HHS
- NIGMS NIH HHS
- U.S. Department of Agriculture (USDA) National Institute for Food and Agriculture (NIFA)
- Center of Biomedical Research Excellence (COBRE) for Translational Chemical Biology
- National Center for Advancing Translational Sciences, National Institutes of Health
- University of Kentucky Igniting Research Collaborations program
Zitieren
APA
Abouelela, M. E., & Helmy, Y. A. (2024). Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. Microorganisms, 12(3), 430. https://doi.org/10.3390/microorganisms12030430
Vancouver
Abouelela ME, Helmy YA. Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. Microorganisms. 2024;12(3):430. doi:10.3390/microorganisms12030430
BibTeX
@article{Abouelela2024,
author = {Abouelela, Mohamed E and Helmy, Yosra A},
title = {Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {3},
pages = {430},
doi = {10.3390/microorganisms12030430}
}
EUVIMED